Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.
Bar-Shira, Anat
Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries. [electronic resource] - Neurogenetics Oct 2009 - 355-8 p. digital
Publication Type: Historical Article; Journal Article; Research Support, Non-U.S. Gov't
1364-6753
10.1007/s10048-009-0186-0 doi
Alleles
Amino Acid Substitution
Founder Effect
Genetic Markers
Genetic Predisposition to Disease
Haplotypes
History, Ancient
Humans
Jews--genetics
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Parkinson Disease--genetics
Point Mutation
Protein Serine-Threonine Kinases--genetics
Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries. [electronic resource] - Neurogenetics Oct 2009 - 355-8 p. digital
Publication Type: Historical Article; Journal Article; Research Support, Non-U.S. Gov't
1364-6753
10.1007/s10048-009-0186-0 doi
Alleles
Amino Acid Substitution
Founder Effect
Genetic Markers
Genetic Predisposition to Disease
Haplotypes
History, Ancient
Humans
Jews--genetics
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Parkinson Disease--genetics
Point Mutation
Protein Serine-Threonine Kinases--genetics